83_FR_51142 83 FR 50946 - Center for Scientific Review; Notice of Closed Meetings

83 FR 50946 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 196 (October 10, 2018)

Page Range50946-50947
FR Document2018-21898

Federal Register, Volume 83 Issue 196 (Wednesday, October 10, 2018)
[Federal Register Volume 83, Number 196 (Wednesday, October 10, 2018)]
[Notices]
[Pages 50946-50947]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-21898]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Neurobiology of Learning and Memory.
    Date: October 24, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Fairmont Washington, DC, 2401 M Street NW, 
Washington, DC 20037.
    Contact Person: Alexei Kondratyev, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 
20892, 301-435-1785, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR Panel: Health Disparities in and Caregiving for 
Alzheimer's Disease.
    Date: November 2, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Contact Person: Gabriel B. Fosu, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3108, MSC 7808, Bethesda, MD 
20892, (301) 435-3562, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowship: Infectious Diseases and Microbiology.
    Date: November 5-6, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Palomar, 2121 P Street NW, Washington, DC 20037.
    Contact Person: Tamara Lyn McNealy, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3188, Bethesda, MD 20892, 301-
827-2372, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Risk, Prevention and Health Behavior.
    Date: November 5-6, 2018.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW, Washington, DC 20015.
    Contact Person: Martha M. Faraday, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 
20892, (301) 435-3575, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Bioengineering Sciences and Technologies.

[[Page 50947]]

    Date: November 5, 2018.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Nitsa Rosenzweig, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4152, MSC 7760, Bethesda, MD 
20892, (301) 404-7419, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Nephrology.
    Date: November 5, 2018.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Julia Spencer Barthold, MD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Traumatic Brain Injury.
    Date: November 5, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Alexander Yakovlev, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD 
20892-7846, 301-435-1254, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Healthcare Delivery and Methodologies.
    Date: November 5, 2018.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD 
20892, (301) 806-0009, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 2, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-21898 Filed 10-9-18; 8:45 am]
 BILLING CODE 4140-01-P



                                              50946                     Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Notices

                                              and Drug Administration, 10001 New                      proposed generic TDS products. FDA                    the discussions could disclose
                                              Hampshire Ave., Hillandale Building,                    also specifically invites comments                    confidential trade secrets or commercial
                                              4th Floor, Silver Spring, MD 20993–                     regarding the comparative assessment of               property such as patentable material,
                                              0002. Send one self-addressed adhesive                  sensitization itself, i.e., whether there             and personal information concerning
                                              label to assist that office in processing               are clinical scenarios where a                        individuals associated with the grant
                                              your requests. See the SUPPLEMENTARY                    comparative sensitization assessment                  applications, the disclosure of which
                                              INFORMATION section for electronic                      may be uninformative when done in                     would constitute a clearly unwarranted
                                              access to the draft guidance document.                  addition to a comparative irritation                  invasion of personal privacy.
                                              FOR FURTHER INFORMATION CONTACT:                        assessment.                                             Name of Committee: Center for Scientific
                                              Diana Solana-Sodeinde, Center for Drug                     This draft guidance is being issued                Review Special Emphasis Panel;
                                              Evaluation and Research, Food and                       consistent with FDA’s good guidance                   Neurobiology of Learning and Memory.
                                              Drug Administration, 10903 New                          practices regulation (21 CFR 10.115).                   Date: October 24, 2018.
                                              Hampshire Ave., Bldg. 75, Rm. 2724,                     The draft guidance, when finalized, will                Time: 8:00 a.m. to 5:00 p.m.
                                                                                                      represent the current thinking of FDA                   Agenda: To review and evaluate grant
                                              Silver Spring, MD 20993–0002, 240–                                                                            applications.
                                              402–3908.                                               on ‘‘Assessing the Irritation and
                                                                                                                                                              Place: The Fairmont Washington, DC, 2401
                                              SUPPLEMENTARY INFORMATION:
                                                                                                      Sensitization Potential of Transdermal                M Street NW, Washington, DC 20037.
                                                                                                      and Topical Delivery Systems for                        Contact Person: Alexei Kondratyev, Ph.D.,
                                              I. Background                                           ANDAs.’’ It does not establish any rights             Scientific Review Officer, Center for
                                                 FDA is announcing the availability of                for any person and is not binding on                  Scientific Review, National Institutes of
                                              a draft guidance for industry entitled                  FDA or the public. You can use an                     Health, 6701 Rockledge Drive, Room 5200,
                                                                                                      alternative approach if it satisfies the              MSC 7846, Bethesda, MD 20892, 301–435–
                                              ‘‘Assessing the Irritation and                                                                                1785, kondratyevad@csr.nih.gov.
                                              Sensitization Potential of Transdermal                  requirements of the applicable statutes
                                                                                                      and regulations. This guidance is not                   Name of Committee: Center for Scientific
                                              and Topical Delivery Systems for                                                                              Review Special Emphasis Panel; PAR Panel:
                                              ANDAs.’’                                                subject to Executive Order 12866.
                                                                                                                                                            Health Disparities in and Caregiving for
                                                 The components and composition of                    II. Paperwork Reduction Act of 1995                   Alzheimer’s Disease.
                                              a TDS formulation, including the nature                                                                         Date: November 2, 2018.
                                                                                                         This draft guidance refers to                        Time: 8:00 a.m. to 5:00 p.m.
                                              of the drug substance and/or the
                                                                                                      previously approved collections of                      Agenda: To review and evaluate grant
                                              occlusivity of the TDS materials, in
                                                                                                      information found in FDA regulations.                 applications.
                                              conjunction with other factors such as
                                                                                                      These collections of information are                    Place: National Institutes of Health, 6701
                                              the environmental humidity or the                                                                             Rockledge Drive, Bethesda, MD 20892.
                                                                                                      subject to review by the Office of
                                              condition of the skin, may have the                                                                             Contact Person: Gabriel B. Fosu, Ph.D.,
                                                                                                      Management and Budget (OMB) under
                                              potential to irritate the skin or lead to                                                                     Scientific Review Officer, Center for
                                                                                                      the Paperwork Reduction Act of 1995
                                              a sensitization reaction. Such reactions                                                                      Scientific Review, National Institutes of
                                                                                                      (44 U.S.C. 3501–3520). The collections                Health, 6701 Rockledge Drive, Room 3108,
                                              can be unpleasant to the patient and
                                                                                                      of information in 21 CFR 314.94 have                  MSC 7808, Bethesda, MD 20892, (301) 435–
                                              may affect patient compliance, skin
                                                                                                      been approved under OMB control                       3562, fosug@csr.nih.gov.
                                              permeability, and/or adhesion of the
                                                                                                      number 0910–0001.                                       Name of Committee: Center for Scientific
                                              TDS to the skin. The collective
                                              consequence of these potential effects                                                                        Review Special Emphasis Panel; Fellowship:
                                                                                                      III. Electronic Access
                                                                                                                                                            Infectious Diseases and Microbiology.
                                              could create uncertainty about the                         Persons with access to the internet                  Date: November 5–6, 2018.
                                              resulting drug delivery profile and                     may obtain the draft guidance at either                 Time: 8:00 a.m. to 5:00 p.m.
                                              uncertainty about the rate and extent of                https://www.fda.gov/Drugs/Guidance                      Agenda: To review and evaluate grant
                                              drug absorption from the TDS.                           ComplianceRegulatoryInformation/                      applications.
                                              Therefore, applicants should perform a                                                                          Place: Hotel Palomar, 2121 P Street NW,
                                                                                                      Guidances/default.htm or https://                     Washington, DC 20037.
                                              comparative assessment of the test (T)                  www.regulations.gov.
                                              and reference (R) TDS products using an                                                                         Contact Person: Tamara Lyn McNealy,
                                                                                                        Dated: October 3, 2018.                             Ph.D., Scientific Review Officer, Center for
                                              appropriately designed skin I/S study                                                                         Scientific Review, National Institutes of
                                              with human subjects to demonstrate                      Leslie Kux,
                                                                                                                                                            Health, 6701 Rockledge Drive, Room 3188,
                                              that the potential for a skin irritation or             Associate Commissioner for Policy.                    Bethesda, MD 20892, 301–827–2372,
                                              sensitization reaction with the T TDS is                [FR Doc. 2018–21958 Filed 10–9–18; 8:45 am]           tamara.mcnealy@nih.gov.
                                              no worse than the reaction observed                     BILLING CODE 4164–01–P                                  Name of Committee: Center for Scientific
                                              with the R TDS.                                                                                               Review Special Emphasis Panel;
                                                 This draft guidance provides                                                                               Fellowships: Risk, Prevention and Health
                                              recommendations for the design and                      DEPARTMENT OF HEALTH AND                              Behavior.
                                              conduct of studies to evaluate the in                   HUMAN SERVICES                                          Date: November 5–6, 2018.
                                                                                                                                                              Time: 8:00 a.m. to 5:00 p.m.
                                              vivo skin I/S potential of a proposed                                                                           Agenda: To review and evaluate grant
                                              TDS. The recommendations in this draft                  National Institutes of Health
                                                                                                                                                            applications.
                                              guidance relate exclusively to studies                                                                          Place: Embassy Suites at the Chevy Chase
                                                                                                      Center for Scientific Review; Notice of
                                              submitted in support of an ANDA.                                                                              Pavilion, 4300 Military Road NW,
                                                                                                      Closed Meetings
                                                 The Agency is seeking comments on                                                                          Washington, DC 20015.
                                              the recommendations reflected in the                      Pursuant to section 10(d) of the                      Contact Person: Martha M. Faraday, Ph.D.,
                                              draft guidance announced in this notice.                Federal Advisory Committee Act, as                    Scientific Review Officer, Center for
amozie on DSK3GDR082PROD with NOTICES1




                                              In addition, FDA invites comments on                                                                          Scientific Review, National Institutes of
                                                                                                      amended, notice is hereby given of the                Health, 6701 Rockledge Drive, Room 3110,
                                              the scales and any alternative                          following meetings.                                   MSC 7808, Bethesda, MD 20892, (301) 435–
                                              approaches, including those                               The meetings will be closed to the                  3575, faradaym@csr.nih.gov.
                                              recommended by international                            public in accordance with the                           Name of Committee: Center for Scientific
                                              regulatory agencies, that may have been                 provisions set forth in sections                      Review Special Emphasis Panel; Member
                                              used with success for the comparative                   552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,            Conflict: Bioengineering Sciences and
                                              assessment of the I/S potential for                     as amended. The grant applications and                Technologies.



                                         VerDate Sep<11>2014   21:20 Oct 09, 2018   Jkt 247001   PO 00000   Frm 00063   Fmt 4703   Sfmt 4703   E:\FR\FM\10OCN1.SGM   10OCN1


                                                                        Federal Register / Vol. 83, No. 196 / Wednesday, October 10, 2018 / Notices                                                 50947

                                                Date: November 5, 2018.                               DEPARTMENT OF HOMELAND                                  Further, you are authorized to make
                                                Time: 11:00 a.m. to 3:00 p.m.                         SECURITY                                              changes to this declaration for the approved
                                                Agenda: To review and evaluate grant                                                                        assistance to the extent allowable under the
                                              applications.                                           Federal Emergency Management                          Stafford Act.
                                                Place: National Institutes of Health, 6701            Agency
                                              Rockledge Drive, Bethesda, MD 20817,
                                                                                                                                                               The time period prescribed for the
                                              (Telephone Conference Call).                            [Internal Agency Docket No. FEMA–4396–                implementation of section 310(a),
                                                Contact Person: Nitsa Rosenzweig, Ph.D.,              DR; Docket ID FEMA–2018–0001]                         Priority to Certain Applications for
                                              Scientific Review Officer, Center for                                                                         Public Facility and Public Housing
                                              Scientific Review, National Institutes of               Commonwealth of the Northern                          Assistance, 42 U.S.C. 5153, shall be for
                                              Health, 6701 Rockledge Drive, Room 4152,                Mariana Islands; Major Disaster and                   a period not to exceed six months after
                                              MSC 7760, Bethesda, MD 20892, (301) 404–                Related Determinations                                the date of this declaration.
                                              7419, rosenzweign@csr.nih.gov.                                                                                   The Federal Emergency Management
                                                Name of Committee: Center for Scientific              AGENCY: Federal Emergency
                                                                                                                                                            Agency (FEMA) hereby gives notice that
                                              Review Special Emphasis Panel; Member                   Management Agency, DHS.
                                                                                                                                                            pursuant to the authority vested in the
                                              Conflict: Topics in Nephrology.                         ACTION: Notice.                                       Administrator, under Executive Order
                                                Date: November 5, 2018.                                                                                     12148, as amended, Benigno Bern Ruiz,
                                                Time: 1:00 p.m. to 4:00 p.m.                          SUMMARY:    This is a notice of the
                                                                                                      Presidential declaration of a major                   of FEMA is appointed to act as the
                                                Agenda: To review and evaluate grant
                                              applications.                                           disaster for the Commonwealth of the                  Federal Coordinating Officer for this
                                                Place: National Institutes of Health, 6701            Northern Mariana Islands (FEMA–4396–                  major disaster.
                                              Rockledge Drive, Bethesda, MD 20892,                    DR), dated September 29, 2018, and                       The following areas of the
                                              (Telephone Conference Call).                            related determinations.                               Commonwealth of the Northern Mariana
                                                Contact Person: Julia Spencer Barthold,               DATES: The declaration was issued
                                                                                                                                                            Islands have been designated as
                                              MD, Scientific Review Officer, Center for
                                                                                                      September 29, 2018.                                   adversely affected by this major disaster:
                                              Scientific Review, National Institutes of
                                                                                                      FOR FURTHER INFORMATION CONTACT:                        The islands of Rota, Saipan, and Tinian for
                                              Health, 6701 Rockledge Drive, Bethesda, MD
                                                                                                      Dean Webster, Office of Response and                  Individual Assistance.
                                              20892, julia.barthold@nih.gov.
                                                                                                                                                              The islands of Rota, Saipan and Tinian for
                                                Name of Committee: Center for Scientific              Recovery, Federal Emergency
                                                                                                                                                            Public Assistance.
                                              Review Special Emphasis Panel; Member                   Management Agency, 500 C Street SW,                     All areas within the Commonwealth of the
                                              Conflict: Traumatic Brain Injury.                       Washington, DC 20472, (202) 646–2833.                 Northern Mariana Islands are eligible for
                                                Date: November 5, 2018.                               SUPPLEMENTARY INFORMATION: Notice is                  assistance under the Hazard Mitigation Grant
                                                Time: 1:00 p.m. to 5:00 p.m.                          hereby given that, in a letter dated                  Program.
                                                Agenda: To review and evaluate grant                  September 29, 2018, the President                       The following Catalog of Federal Domestic
                                              applications.
                                                                                                      issued a major disaster declaration                   Assistance Numbers (CFDA) are to be used
                                                Place: National Institutes of Health, 6701                                                                  for reporting and drawing funds: 97.030,
                                              Rockledge Drive, Bethesda, MD 20892,                    under the authority of the Robert T.
                                                                                                      Stafford Disaster Relief and Emergency                Community Disaster Loans; 97.031, Cora
                                              (Telephone Conference Call).                                                                                  Brown Fund; 97.032, Crisis Counseling;
                                                Contact Person: Alexander Yakovlev,                   Assistance Act, 42 U.S.C. 5121 et seq.
                                                                                                                                                            97.033, Disaster Legal Services; 97.034,
                                              Ph.D., Scientific Review Officer, Center for            (the ‘‘Stafford Act’’), as follows:
                                                                                                                                                            Disaster Unemployment Assistance (DUA);
                                              Scientific Review, National Institutes of                  I have determined that the damage in               97.046, Fire Management Assistance Grant;
                                              Health, 6701 Rockledge Drive, Room 5206,                certain areas of the Commonwealth of the              97.048, Disaster Housing Assistance to
                                              MSC 7846, Bethesda, MD 20892–7846, 301–                 Northern Mariana Islands resulting from               Individuals and Households In Presidentially
                                              435–1254, yakovleva@csr.nih.gov.                        Typhoon Mangkhut during the period of                 Declared Disaster Areas; 97.049,
                                                Name of Committee: Center for Scientific              September 10 to September 11, 2018, is of             Presidentially Declared Disaster Assistance—
                                              Review Special Emphasis Panel; Member                   sufficient severity and magnitude to warrant          Disaster Housing Operations for Individuals
                                              Conflict: Healthcare Delivery and                       a major disaster declaration under the Robert         and Households; 97.050, Presidentially
                                              Methodologies.                                          T. Stafford Disaster Relief and Emergency             Declared Disaster Assistance to Individuals
                                                Date: November 5, 2018.                               Assistance Act, 42 U.S.C. 5121 et seq. (the           and Households—Other Needs; 97.036,
                                                Time: 12:00 p.m. to 3:00 p.m.                         ‘‘Stafford Act’’). Therefore, I declare that such     Disaster Grants—Public Assistance
                                                Agenda: To review and evaluate grant                  a major disaster exists in the Commonwealth           (Presidentially Declared Disasters); 97.039,
                                              applications.                                           of the Northern Mariana Islands.                      Hazard Mitigation Grant.
                                                Place: National Institutes of Health, 6701               In order to provide Federal assistance, you
                                              Rockledge Drive, Bethesda, MD 20892,                    are hereby authorized to allocate from funds          Brock Long,
                                              (Telephone Conference Call).                            available for these purposes such amounts as          Administrator, Federal Emergency
                                                Contact Person: Jacinta Bronte-Tinkew,                you find necessary for Federal disaster               Management Agency.
                                              Ph.D., Scientific Review Officer, Center for            assistance and administrative expenses.               [FR Doc. 2018–21927 Filed 10–9–18; 8:45 am]
                                              Scientific Review, National Institutes of                  You are authorized to provide Individual
                                                                                                                                                            BILLING CODE 9111–11–P
                                              Health, 6701 Rockledge Drive, Room 3164,                Assistance and Public Assistance in the
                                              MSC 7770, Bethesda, MD 20892, (301) 806–                designated areas and Hazard Mitigation
                                              0009, brontetinkewjm@csr.nih.gov.                       throughout the Commonwealth. Consistent
                                                                                                      with the requirement that Federal assistance          DEPARTMENT OF HOMELAND
                                              (Catalogue of Federal Domestic Assistance                                                                     SECURITY
                                                                                                      be supplemental, any Federal funds provided
                                              Program Nos. 93.306, Comparative Medicine;
                                                                                                      under the Stafford Act for Hazard Mitigation
                                              93.333, Clinical Research, 93.306, 93.333,                                                                    Federal Emergency Management
                                                                                                      and Other Needs Assistance will be limited
                                              93.337, 93.393–93.396, 93.837–93.844,                   to 75 percent of the total eligible costs.            Agency
                                              93.846–93.878, 93.892, 93.893, National                 Federal funds provided under the Stafford
amozie on DSK3GDR082PROD with NOTICES1




                                              Institutes of Health, HHS)                              Act for Public Assistance also will be limited        [Internal Agency Docket No. FEMA–4366–
                                                Dated: October 2, 2018.                               to 75 percent of the total eligible costs, with       DR; Docket ID FEMA–2018–0001]
                                              Sylvia L. Neal,                                         the exception of projects that meet the
                                                                                                      eligibility criteria for a higher Federal cost-       Hawaii; Amendment No. 4 to Notice of
                                              Program Analyst, Office of Federal Advisory
                                                                                                      sharing percentage under the Public                   a Major Disaster Declaration
                                              Committee Policy.
                                                                                                      Assistance Alternative Procedures Pilot
                                              [FR Doc. 2018–21898 Filed 10–9–18; 8:45 am]             Program for Debris Removal implemented                AGENCY:Federal Emergency
                                              BILLING CODE 4140–01–P                                  pursuant to section 428 of the Stafford Act.          Management Agency, DHS.


                                         VerDate Sep<11>2014   21:20 Oct 09, 2018   Jkt 247001   PO 00000   Frm 00064   Fmt 4703   Sfmt 4703   E:\FR\FM\10OCN1.SGM   10OCN1



Document Created: 2018-10-10 17:37:17
Document Modified: 2018-10-10 17:37:17
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOctober 24, 2018.
FR Citation83 FR 50946 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR